In our study, it is documented that serum the level of DKK1, an inhibitor of Wnt signaling pathway is decreased, while glandular tissue Wnt1 and Wnt3a expressions are relatively higher, in patients with primary SS. This evidence concerns the gene WNT1 and synovial sarcoma.